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Purpose of the study
A pilot study was initiated in Autumn 2009 to better
define which diseases have a HIV prevalence of >0.1 %
a sH I Vt e s t i n go fp o p u l a t i o n sw i t haH I Vp r e v a l e n c e
above this has shown to be cost-effective. The prelimin-
ary results are reported here.
Methods
A detailed questionnaire was completed for persons pre-
senting with 8 different indicator diseases; sexually
transmitted disease (STD), malignant lymphoma (LYM),
cervical or anal cancer/dysplasia (CAN), herpes zoster
(HER), ongoing mononucleosis-like illness (MON),
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>4 weeks (CYT), and seborrheic dermatitis/exanthema
(SEB).
Results
1482 persons have so far been included in the pilot
phase by June 2010 from 29 surveys taking place in
Austria, Belarus, Belgium, Bosnia, Croatia, Denmark,
Germany, Italy, Poland, Spain, Sweden and Ukraine.
Selected characteristics of the patients are shown in Fig-
ure 1. Almost 40% reported a previous HIV test; this
was highest in the STD (59.0%), HEP (47.5%) and SEB
(44.2%) groups. Median age was highest in the LYM
group (53 years), and youngest in the MON group (24
years). 104 persons (7.7%) reported one of 5 specific
HIV-related symptoms in the previous 5 years (mono-
nucleosis, oral candidiasis, herpes zoster, unexplained
leukocytopenia/thrombocytopenia or seborrheic derma-
titis); these symptoms were highest in the HER (33.3%),
SEB (31.1%) and LYM (21.2%) groups. 134 had visited
an STD clinic in the previous 5 years including over half
of the STD group (56.3%). 152 had been hospitalised in
the previous 5 years; the highest proportion was seen in
t h eH E Pg r o u p( 7 0 . 3 % ) .M a n yo ft h ep l a n n e ds u r v e y s
have shown difficult to implement because of reluctance
towards introducing routine HIV testing among specia-
l i s t sw h oa r en o tu s e dt o / w o r r i e da b o u tp e r f o r m i n ga n
HIV test. A number of persons have tested HIV-
positive.
Conclusions
The first results of this pilot study demonstrates the
potential benefit of guided HIV testing of patients with
selected indicator diseases, as a number of persons have
been identified to be HIV-positive. A significant propor-
tion of the persons had previously been hospitalised or
reported HIV-associated symptoms but had not been
tested. Physicians in some specialities are however reluc-
tant to adopt this testing strategy.
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